Update: 4th extension project to advance oncology candidate with global pharma company

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a further extension to a Virtual Tumour project with a major global pharmaceutical company, first announced on 1^st March 2012.  The extension will cover predicting optimal regimens for a further candidate compound and should be completed by the end of 2014… Read more